Horizon Kinetics Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.1M	Sell	12,192 -388	-3%	-$71.9K	0.02%	116
2025 Q4	$2.51M	Sell	12,580 -329	-3%	-$59.7K	0.03%	99
2025 Q3	$2.02M	Sell	12,909 -9,351	-42%	-$1.49M	0.02%	117
2025 Q2	$3.38M	Sell	22,260 -12,026	-35%	-$1.6M	0.04%	89
2025 Q1	$5.16M	Sell	34,286 -25,554	-43%	-$4.28M	0.06%	68
2024 Q4	$11M	Sell	59,840 -54,922	-48%	-$10.6M	0.14%	48
2024 Q3	$22.6M	Sell	114,762 -45,619	-28%	-$9.48M	0.34%	34
2024 Q2	$33.1M	Buy	160,381 +1,170	+0.7%	+$265K	0.58%	20
2024 Q1	$43.1M	Sell	159,211 -23,453	-13%	-$5.6M	0.82%	15
2023 Q4	$43.2M	Sell	182,664 -31,571	-15%	-$6.21M	0.9%	17
2023 Q3	$42M	Sell	214,235 -18,265	-8%	-$3.75M	0.83%	19
2023 Q2	$48.9M	Sell	232,500 -14,468	-6%	-$2.88M	1.06%	15
2023 Q1	$49.8M	Sell	246,968 -13,125	-5%	-$2.97M	0.96%	16
2022 Q4	$56.7M	Sell	260,093 -24,296	-9%	-$5.31M	0.94%	14
2022 Q3	$56M	Sell	284,389 -14,585	-5%	-$3.15M	1.13%	11
2022 Q2	$64M	Buy	298,974 +23,735	+9%	+$5.8M	1.34%	12
2022 Q1	$78.2M	Buy	275,239 +47,933	+21%	+$14.8M	1.58%	10
2021 Q4	$85.6M	Buy	227,306 +19,514	+9%	+$7.58M	1.9%	7
2021 Q3	$85.7M	Buy	207,792 +11,038	+6%	+$4.58M	2.01%	7
2021 Q2	$72.8M	Buy	196,754 +75,962	+63%	+$25.4M	1.49%	8
2021 Q1	$35M	Buy	120,792 +9,074	+8%	+$2.52M	0.8%	19
2020 Q4	$27.9M	Sell	111,718 -2,889	-3%	-$688K	0.93%	21
2020 Q3	$26M	Buy	114,607 +654	+0.6%	+$136K	1.05%	20
2020 Q2	$19.9M	Buy	113,953 +75,262	+195%	+$12M	0.72%	23
2020 Q1	$4.88M	Buy	+38,691	New	+$5.8M	0.22%	53